Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall Street - shutterstock_1321462394
Stock Index Futures Move Lower as U.S. Debt Ceiling Uncertainty Weighs on Sentiment, PMI Data in Focus Barchart - Tue May 23, 2023

June S&P 500 futures (ESM23) are down -0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.02% this morning as the U.S. debt ceiling impasse kept risk sentiment fragile, while market participants...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
NKE : 75.43 (+0.25%)
BAER.Z.IX : 52.180 (-0.19%)
MYGN : 25.02 (+0.28%)
LFCR : 4.87 (-1.22%)
MVST : 0.3994 (+6.85%)
GH : 28.74 (+1.16%)
QTRX : 12.22 (-2.40%)
Quanterix’s First Quarter 2023 Earnings Conference Call Business Wire - Tue May 2, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, May 9, 2023, to discuss...

QTRX : 12.22 (-2.40%)
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials Business Wire - Tue Apr 25, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that blood-based NfL measurements provided...

QTRX : 12.22 (-2.40%)
Quanterix to Participate in Barclays Global Healthcare Conference Business Wire - Wed Mar 8, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays...

QTRX : 12.22 (-2.40%)
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations Business Wire - Mon Mar 6, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended...

QTRX : 12.22 (-2.40%)
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference Business Wire - Tue Feb 28, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s...

QTRX : 12.22 (-2.40%)
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call Business Wire - Fri Feb 24, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss...

QTRX : 12.22 (-2.40%)
Mercy BioAnalytics Announces Executive Leadership Changes Business Wire - Wed Feb 15, 2023

Mercy BioAnalytics, Inc. , a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that Dawn Mattoon, PhD, has assumed the role of Chief Executive Officer...

QTRX : 12.22 (-2.40%)
TMO : 539.95 (+0.81%)
Quanterix Announces Appointment of Brian Blaser to Board of Directors Business Wire - Mon Jan 9, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective...

QTRX : 12.22 (-2.40%)
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test Business Wire - Mon Jan 9, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory Developed...

QTRX : 12.22 (-2.40%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - 1 hour ago
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot